VC fund profile · evidence-aware directory data

Norwest Venture Partners stages, portfolio and investment profile

Palo Alto multi-stage firm investing across consumer, enterprise, healthcare, and fintech from seed through growth equity — backed by long-duration Wells Fargo capital.

Keep track of Norwest Venture Partners

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Series A, Series B+

Participates: Seed, Series A, Series B+

Sector focus

Enterprise SaaS · Fintech · Healthtech · Consumer

Geography

Palo Alto, CA

Founded 1961

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Alice

Growth · $140M · August 2026

Rounds they lead

Series A Series B+

Rounds they invest

Seed Series A Series B+

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list Norwest Venture Partners as an investor (9 total).

FAQs about Norwest Venture Partners

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Norwest leads Series A and Series B+ in our directory and participates at seed. The firm spans early venture through growth equity — NVP XV was a $2B combined fund (its largest) investing across all stages.

Norwest's venture team publicly cites $1M–$30M equity checks: smaller initial seed/Series A tickets of $1M–$5M scaling to $10M–$30M in later venture rounds. Growth equity checks can reach $20M–$100M+ for scale-stage companies.

Norwest is headquartered in Palo Alto/Menlo Park with offices in San Francisco, India, and Israel. The firm invests globally in technology-enabled businesses across its three core sectors: consumer, enterprise, and healthcare.

Our directory tags enterprise-saas, fintech, healthtech, and consumer. Norwest emphasizes durable categories — B2B software with recurring revenue, digital health, and consumer brands with scalable distribution.

Norwest leads and co-leads across stages within the same fund structure, allowing founders to keep one partner from seed through growth. The firm reports investing $10M–$15M in many companies over their lifecycle.

Linked startups include Omada Health (/startup/omada-health), OpenDoor (/startup/opendoor), IFTTT (/startup/ifttt), Flyhomes (/startup/flyhomes), Science Exchange (/startup/science-exchange), and Rezo Therapeutics (/startup/rezo-therapeutics).

Use nvp.com and identify sector partners (consumer, enterprise, healthcare). Warm introductions from portfolio founders or co-investors are standard. Norwest's patient capital model suits founders planning multi-round journeys without switching lead investors.

August 2026: Norwest returned on Alice’s $140 million raise (ex-ActiveFence; company post; valuation is press, not in the company note) — /2026-august-25-26-investment-news-grid-freight-media. Norwest also appears in startup investor lists across healthtech and proptech profiles such as Omada Health and Flyhomes.

Website

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.